Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.88
+0.13 (0.75%)
At close: Sep 11, 2026, 4:00 PM EDT
16.85
-0.02 (-0.15%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $89.61 million as of September 11, 2026. Its market cap has increased by 257.43% in one year.
Market Cap
89.61M
Enterprise Value
-3.23M
1-Year Change
257.43%
Ranking
Category
Stock Price
$16.88
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $89.61M, a decrease of -77.91%. That is a compound annual growth rate of -25.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 89.61M | 209.19% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 95.06M |
| Atara Biotherapeutics | 94.15M |
| Cardiff Oncology | 94.13M |
| Anixa Biosciences | 93.90M |
| Cognition Therapeutics | 93.46M |
| NeOnc Technologies Holdings | 91.47M |
| ImmuCell | 89.41M |
| MediciNova | 89.09M |